Search details
1.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34253871
2.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33024268
3.
Cancer immunotherapy in patients with brain metastases.
Cancer Immunol Immunother
; 67(5): 703-711, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29520474
4.
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Oncology
; 93(1): 62-66, 2017.
Article
in English
| MEDLINE | ID: mdl-28407622
5.
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients-A Retrospective Observational Study.
Cancers (Basel)
; 15(13)2023 Jun 30.
Article
in English
| MEDLINE | ID: mdl-37444532
6.
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis.
Anticancer Res
; 43(2): 755-763, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36697101
7.
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review.
Cancer Biother Radiopharm
; 38(4): 232-245, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36622960
8.
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.
Front Oncol
; 13: 1160673, 2023.
Article
in English
| MEDLINE | ID: mdl-37064137
9.
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study.
Oncotarget
; 13: 686-693, 2022.
Article
in English
| MEDLINE | ID: mdl-35574217
10.
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.
Cancers (Basel)
; 14(3)2022 Feb 04.
Article
in English
| MEDLINE | ID: mdl-35159069
11.
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis.
Anticancer Res
; 42(2): 991-1000, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35093899
12.
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management.
Front Oncol
; 12: 1026978, 2022.
Article
in English
| MEDLINE | ID: mdl-36713496
13.
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
Clin Colorectal Cancer
; 21(3): 220-228, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35304089
14.
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Cancers (Basel)
; 14(7)2022 Mar 29.
Article
in English
| MEDLINE | ID: mdl-35406515
15.
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature.
Cancer Lett
; 507: 89-96, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33744389
16.
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study.
Cancers (Basel)
; 13(24)2021 Dec 17.
Article
in English
| MEDLINE | ID: mdl-34944975
17.
Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 19(4): e272-e276, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32768271
18.
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 12(9)2020 Sep 14.
Article
in English
| MEDLINE | ID: mdl-32937860
19.
Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients.
Cancers (Basel)
; 12(12)2020 Dec 04.
Article
in English
| MEDLINE | ID: mdl-33291569
20.
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer.
Oncotarget
; 11(45): 4115-4122, 2020 Nov 10.
Article
in English
| MEDLINE | ID: mdl-33227095